ArticleNarra J2025

In silico studies on quercetin, myricetin, and kaempferol in inhibiting TGF-β1 and galectin- 3 for cardiac fibrosis management.

Suryono Suryono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.